Treatment
Drug clinical trials
We’re tracking 1,253 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT07012148RecruitingEarly Phase 1
Seizure forecasting device for temporal lobe epilepsy
This study tests a small device placed under the scalp that may help predict when seizures are likely to happen, using EEG (brain wave) readings. It is designed for people with temporal lobe epilepsy to improve seizure management and safety.
Scottsdale, ArizonaAges 18–75 - NCT07004166Recruiting
New injection techniques to reduce pain and leakage
This study tests two different injection methods (TPR and Z-track) to see if they cause less pain and less medication leakage when giving the painkiller diclofenac sodium into the hip muscle.
SivasAges 18–40 - NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Düsseldorf, North Rhine-WestphaliaAges 18–44 - NCT07001267Recruiting
Comparing two anesthetics for stroke procedure recovery
This trial tests whether a sedative given through an IV or a gas you breathe affects recovery after surgery to remove a blood clot in the brain. It may help find the best way to keep you comfortable during the procedure to improve how well you do after three months.
Kansas City, KansasAges 18 years+ - NCT06998966Recruiting
Improving PPI prescribing with electronic help
This study tests if a tool in the electronic health record can help doctors prescribe proton pump inhibitors (medicines for heartburn) more effectively. It may lead to better treatment decisions for patients like you.
Los Angeles, CaliforniaAges 50 years+ - NCT06999616Recruiting
Physical activity program for cancer patients in day clinic
This trial tests a nurse-led physical activity program for cancer patients receiving treatment at an outpatient clinic. It aims to help you stay active during your cancer care.
MünsterlingenAges 18 years+ - NCT07000084RecruitingPhase 3
Testing gemcitabine with BCG for returning bladder cancer
This trial tests whether adding a chemotherapy drug called gemcitabine to the usual BCG therapy can help prevent bladder cancer from coming back again. If you have had BCG before and your cancer returned, this study might offer a more effective treatment option.
Birmingham, AlabamaAges 18 years+ - NCT04934228RecruitingPhase 1
Study targeting inflammation in people with obesity and high blood pressure
This Phase 1 study looks at a treatment aimed at reducing “inflammation patterns” that are common in obesity and insulin resistance. If you meet specific health and lab criteria, you may be asked to visit a research lab and provide blood samples to see how the treatment affects your body.
Kansas City, KansasAges 18–79 - NCT06983080RecruitingPhase 2
Trazodone for better sleep in older adults
This study tests whether trazodone, a sleep medication, improves insomnia in people 65 and older. You might benefit if you struggle with falling or staying asleep and are not already taking other sleep aids.
Montreal, QuebecAges 65 years+ - NCT06119269Recruiting
Ponatinib for chronic phase CML
This study looks at how the drug ponatinib works in people with chronic phase CML. It aims to understand how the body handles the drug and if it helps control the leukemia.
CagliariAges 18 years+ - NCT06977724RecruitingPhase 1
Testing a new drug for lupus, sjogren's, and rheumatoid arthritis
This study tests an experimental medicine given by IV infusion to see if it is safe and helps reduce symptoms of lupus, sjogren's disease, or rheumatoid arthritis. It is an early-phase trial, so the main goals are checking side effects and how the drug behaves in the body, but it will also look at how well it works.
Avon Park, FloridaAges 18–75 - NCT06979453RecruitingPhase 3
A study of deucravacitinib for teens with plaque psoriasis
This trial tests an investigational oral medication called deucravacitinib for teenagers (adolescents) with moderate to severe plaque psoriasis. It aims to see if the drug is safe and works well.
Birmingham, AlabamaAges 12–17 - NCT06978816Recruiting
Ear pressure points plus pain meds for kidney stone relief
This study tests whether pressing specific points on the ear, along with pain medicine, can relieve kidney stone pain faster than pain medicine alone. It's designed for people with confirmed kidney stones and moderate to severe pain who haven't taken pain relievers recently.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06965114RecruitingPhase 1/Phase 2
Testing tovorafenib plus rituximab for hairy cell leukemia
This trial tests a new drug combination (tovorafenib and rituximab) for people with hairy cell leukemia (HCL) whose cancer has a specific genetic change called BRAF V600E. It looks at safety and how well the drugs work, both for people who have had treatment before and for those who have not.
Bethesda, MarylandAges 18 years+ - NCT06971848Recruiting
Skin testing for biologic drug allergies
This trial checks if people can safely receive certain biologic drugs without allergic reactions, using skin tests to see how the body reacts. It may help find out if you are allergic to a biologic medicine you have taken before.
AngersAges 18 years+ - NCT06968507RecruitingPhase 4
Steroid pills vs. ear injections for sudden hearing loss
This trial compares two treatments for sudden hearing loss: steroid pills taken by mouth or steroid injections into the ear. It aims to find which is more effective for patients who developed hearing loss within the last 2 weeks.
Istanbul, KartalAges 18–80 - NCT06972225Recruiting
Study of heart outcomes after drug-coated balloon treatment
This study looks at heart-related complications in adults who had a coronary angioplasty using a drug-eluting balloon. It aims to understand how well these balloons work over time.
Québec, QuebecAges 18 years+ - NCT06969170RecruitingPhase 2
Psilocybin oral solution for generalized anxiety disorder trial
This study tests a psilocybin oral solution in adults with generalized anxiety disorder (GAD). It aims to see if the drug is safe, tolerable, and helpful for reducing anxiety symptoms.
Kingston, OntarioAges 18–60 - NCT06955169RecruitingPhase 2
Study of lutetium treatment for meningioma after prior therapy
This study tests a radioactive drug, lutetium-177 DOTATATE, against standard care for people whose meningioma has grown despite earlier surgery and radiation. The treatment targets a protein on tumor cells, which may slow or stop growth.
Irvine, CaliforniaAges 18 years+ - NCT06953479RecruitingPhase 4
Hepatitis C treatment for people awaiting trial in jail
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
Cranston, Rhode IslandAges 18 years+ - NCT06952868RecruitingPhase 2
BNCT for recurrent head and neck cancer
This trial tests a special type of radiation therapy called BNCT (boron neutron capture therapy) for head and neck cancers that have come back and cannot be removed by surgery. It may be an option for patients who have already had radiation and cannot receive standard chemotherapy.
Chiayi CityAges 18–80 - NCT06928272RecruitingPhase 3
Long COVID drug study for adults 18 to 65
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
San Diego, CaliforniaAges 18–65 - NCT06924697Enrolling by invitation
Testing a diabetes drug to help men quit smoking
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06929533Recruiting
Genetic testing to guide mental health medication
This study tests if using genetic information can help doctors choose the right mental health medication or dose. It may help find treatments that work better with fewer side effects.
Winnipeg, ManitobaAges 18 years+
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,253 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.